ArticleJournal of cardiovascular and thoracic research2024
Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial.
Hossein Behzad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.